Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice
about
Imaging of intestinal fibrosis: current challenges and future methodsAnti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.Inhibition of a novel fibrogenic factor Tl1a reverses established colonic fibrosis.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Quality of care in Crohn's disease.The gut microbiome in intestinal fibrosis: environmental protector or provocateur?Anti-fibrogenic effects of the anti-microbial peptide cathelicidin in murine colitis-associated fibrosis.Infliximab preferentially induces clinical remission and mucosal healing in short course Crohn's disease with luminal lesions through balancing abnormal immune response in gut mucosaThe interplay of extracellular matrix and microbiome in urothelial bladder cancer.Reversibility of Stricturing Crohn's Disease-Fact or Fiction?Novel Rho/MRTF/SRF inhibitors block matrix-stiffness and TGF-β-induced fibrogenesis in human colonic myofibroblastsEpidemiology of the transition from early to late Crohn's disease.Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Mechanisms, Management, and Treatment of Fibrosis in Patients With Inflammatory Bowel Diseases.The orphan nuclear receptor RORα and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.Optimisation of Intestinal Fibrosis and Survival in the Mouse S. Typhimurium Model for Anti-fibrotic Drug Discovery and Preclinical Applications.Chromofungin Ameliorates the Progression of Colitis by Regulating Alternatively Activated Macrophages.Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts2,4,6-trinitrobenzene sulfonic acid-induced chronic colitis with fibrosis and modulation of TGF-β1 signaling.Development of Fibrosis in Acute and Longstanding Ulcerative Colitis.Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease.Fibrocytes, inflammation, and fibrosis in Crohn's disease: another piece of the puzzle.Myeloid differentiation primary response gene (MyD) 88 signalling is not essential for intestinal fibrosis development.Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease.MyD88 signaling promotes both mucosal homeostatic and fibrotic responses during Salmonella-induced colitis.Intestinal organoids: a model of intestinal fibrosis for evaluating anti-fibrotic drugs.Activation of Myofibroblast TRPA1 by Steroids and Pirfenidone Ameliorates Fibrosis in Experimental Crohn's Disease.Ultrasound shear wave elastography helps discriminate low-grade from high-grade bowel wall fibrosis in ex vivo human intestinal specimens.Comparison of noncontrast MRI magnetization transfer and T2 -Weighted signal intensity ratios for detection of bowel wall fibrosis in a Crohn's disease animal model.Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis
P2860
Q26740545-28A904F8-6E8E-4FF6-973C-3B93AD03934EQ33776469-FB1B3BCA-0607-4B7B-AA13-74D58AC5A0AAQ34381832-2E7D5C23-B3FD-47E8-A04F-BB7F94982AC3Q34504710-95C03855-A41A-4EF7-9707-A428025BDADBQ34508859-1973C81E-66A5-448B-99BD-30A6AAFDE53EQ34778411-FBA3B2C3-29C1-4007-AE29-1AE0293038D5Q35113922-D84DAA15-5080-45F1-A8AD-C293402E264DQ35250578-60BA01A1-EA07-4AF0-8479-86D0B95254C7Q35868405-C413196F-4CE7-4C36-8481-70F76F6FAD75Q36373253-471B27A2-234C-46C4-A801-BCB936E2980CQ36970922-46D3F323-D137-4C49-B5E8-1FDBD94D942CQ38026397-74BC26BF-BD37-4AE9-835E-F5D4FAB9997AQ38033380-949F63A1-B055-4EB4-91D5-5E6A70F36911Q38065036-951AD114-877D-41E8-8768-96824F43B24CQ38394726-9269D4A5-6057-4D30-B6F1-2400D117E479Q38976561-1493D874-82F6-44C3-8C88-6779EEC5936AQ40103784-4D33689A-512F-4EF8-89CA-039241714530Q40406061-42BD80D5-882E-4EBB-872E-1C8EA66DA087Q41688556-F42C92C4-D8B8-41EC-8C13-1BA4E8C9F9AEQ42044193-EF7C15D3-66C3-4D75-A054-176CA879E9EAQ43082777-2C04E2A6-10D4-4080-9120-36C0DFAE5676Q44206690-D16F9D20-F209-4C48-84F5-BCF88F822816Q44445378-CE2037B0-6902-43B7-8F86-FF55B0ED4908Q44989287-78D22855-2527-4189-A37A-D0B99DCACD82Q47144405-3CAF3ABB-AE52-41B3-B5C0-1659A73A684AQ47705165-7D5A183C-5F2B-4CD0-9D58-3A14201FD451Q50026253-1ED346F2-DB02-41A1-BBA1-637062ECB709Q50593916-F7C8BA71-F22A-4EC7-961E-14CF9DD9933BQ52430882-74E375CF-0A1B-4781-B0DA-91FED18098DCQ53039594-0D199917-120A-4FC4-81AC-912FFBCB9A8CQ53668892-7F7D9043-84E0-43C2-A3D2-1FF49DAD78DBQ57472735-552C2A61-11F8-42EF-8957-370B1CE83C43
P2860
Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@ast
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@en
type
label
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@ast
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@en
prefLabel
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@ast
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@en
P2093
P2860
P356
P1476
Intestinal fibrosis is reduced ...... to intestinal fibrosis in mice
@en
P2093
David S Moons
Kay Sauder
Laura A Johnson
Peter D R Higgins
P2860
P304
P356
10.1002/IBD.21812
P577
2011-07-14T00:00:00Z